balsalazide disodium
balsalazide disodium is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand name including balsalazide disodium. Available dosage form: capsule.
Drug details
- Generic Name
- balsalazide disodium
- Brand Names
- balsalazide disodium
- Application Number
- ANDA219422
- Sponsor
- Carnegie Pharmaceuticals, LLC
- NDC Codes
- 5
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- BALSALAZIDE DISODIUM
Indications and Usage
1 INDICATIONS AND USAGE Balsalazide disodium capsules are indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older. Limitations of Use Safety and effectiveness of balsalazide beyond 8 weeks in pediatric patients 5 years to 17 years of age and 12 weeks in adults have not been established. Balsalazide is an aminosalicylate indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older. ( 1 ) Limitations of Use: Safety and effectiveness of balsalazide beyond 8 weeks in children (ages 5 to 17 years) and 12 weeks in adults have not been established. ( 1 )